Concepedia

Herbert Struemper

HS

Statistics

Publications

22

Citations

811

H-Index

17

Active since

2005

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

The Netherlands Cancer Institute

Herbert Struemper is an author at GlaxoSmithKline (United States) specializing in medicine, immunology, and pharmacology.

ORCID

Top concepts

Publications per year

2005–2023

22

Publications

22

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola et al. · Annals of the Rheumatic Diseases · 2020 · 179 citations · Full text

Systems biology for battling rheumatoid arthritis: Application of the Entelos PhysioLab platform

J.A.C. Rullmann, Herbert Struemper, Nadine A. Defranoux et al. · Systems Biology · 2005 · 59 citations

, , +18

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

Sophie Postel‐Vinay, Vincent K. Lam, Willeke Ros et al. · Journal for ImmunoTherapy of Cancer · 2023 · 59 citations · Full text

Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study

Fiona Simpkins, Aurea E. Flores, Christina Chu et al. · Cancer Immunology Research · 2013 · 53 citations · Full text

, , +20

Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

Herbert Struemper, Cecil Chen, Wendy Cai · The Journal of Clinical Pharmacology · 2013 · 51 citations

1–5 of 22